HK1210264A1 - 使用纖蛋白- 和/或肌聚糖γ作為指標評價脂肪團的方法和評價脂肪團有效藥物的方法 - Google Patents

使用纖蛋白- 和/或肌聚糖γ作為指標評價脂肪團的方法和評價脂肪團有效藥物的方法

Info

Publication number
HK1210264A1
HK1210264A1 HK15110888.7A HK15110888A HK1210264A1 HK 1210264 A1 HK1210264 A1 HK 1210264A1 HK 15110888 A HK15110888 A HK 15110888A HK 1210264 A1 HK1210264 A1 HK 1210264A1
Authority
HK
Hong Kong
Prior art keywords
cellulite
evaluating
fibulin
indicator
evaluating cellulite
Prior art date
Application number
HK15110888.7A
Other languages
English (en)
Inventor
Yuzo Yoshida
Kentaro Kajiya
Michael Detmar
Original Assignee
Shiseido Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shiseido Co Ltd filed Critical Shiseido Co Ltd
Publication of HK1210264A1 publication Critical patent/HK1210264A1/zh

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6881Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids from skin
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5044Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6881Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for tissue or cell typing, e.g. human leukocyte antigen [HLA] probes
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/136Screening for pharmacological compounds
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/158Expression markers
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/46Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
    • G01N2333/47Assays involving proteins of known structure or function as defined in the subgroups
    • G01N2333/4701Details
    • G01N2333/4703Regulators; Modulating activity
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00Screening for compounds of potential therapeutic value
    • G01N2500/10Screening for compounds of potential therapeutic value involving cells
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/20Dermatological disorders

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Cell Biology (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Organic Chemistry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Toxicology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biophysics (AREA)
  • General Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
HK15110888.7A 2012-09-07 2015-11-04 使用纖蛋白- 和/或肌聚糖γ作為指標評價脂肪團的方法和評價脂肪團有效藥物的方法 HK1210264A1 (zh)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/JP2012/073561 WO2014038097A1 (en) 2012-09-07 2012-09-07 Method of evaluating cellulite and method of evaluating cellulite-effective drug using fibulin-3 and/or sarcoglycan gamma as an indicator

Publications (1)

Publication Number Publication Date
HK1210264A1 true HK1210264A1 (zh) 2016-04-15

Family

ID=46970373

Family Applications (1)

Application Number Title Priority Date Filing Date
HK15110888.7A HK1210264A1 (zh) 2012-09-07 2015-11-04 使用纖蛋白- 和/或肌聚糖γ作為指標評價脂肪團的方法和評價脂肪團有效藥物的方法

Country Status (7)

Country Link
US (2) US9933436B2 (zh)
EP (1) EP2893345B1 (zh)
JP (1) JP6049862B2 (zh)
CN (1) CN104603616B (zh)
ES (1) ES2647895T3 (zh)
HK (1) HK1210264A1 (zh)
WO (1) WO2014038097A1 (zh)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ766918A (en) 2012-01-12 2023-03-31 Auxilium Int Holdings Inc Clostridium histolyticum enzymes and methods for the use thereof
US11123280B2 (en) 2017-03-01 2021-09-21 Endo Ventures Limited Method of assessing and treating cellulite
US11473074B2 (en) 2017-03-28 2022-10-18 Endo Global Aesthetics Limited Method of producing collagenase
WO2024004675A1 (ja) * 2022-07-01 2024-01-04 国立大学法人大阪大学 肝臓癌の発症可能性を検査する方法

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3122177B2 (ja) * 1991-08-09 2001-01-09 旭硝子株式会社 薄膜トランジスタとその製造方法
JP3179887B2 (ja) * 1992-09-02 2001-06-25 ポーラ化成工業株式会社 皮膚メラニンの評価法
JP2002506801A (ja) 1998-03-16 2002-03-05 ザ、プロクター、エンド、ギャンブル、カンパニー 哺乳類の皮膚のセルライトを軽減する方法
ITMI991894A1 (it) * 1999-09-09 2001-03-09 Carlo Ghisalberti Acido linoleico coniugato e trigliceride nuovi metodi di sintesi e d'uso
WO2004080147A2 (en) 2003-03-13 2004-09-23 Alfatech Medical Systems Ltd. Cellulite ultrasound treatment
US20060094054A1 (en) * 2004-11-04 2006-05-04 National Jewish Medical And Research Center Fibulin-3 and uses thereof
ES2298885T3 (es) * 2005-06-30 2008-05-16 Evonik Goldschmidt Gmbh Utilizacion de una base saliciloil-esfingoide para el tratamiento o la prevencion de la celulitis.
US20070031482A1 (en) * 2005-08-02 2007-02-08 Ceramoptec Industries, Ind. PDT treatment method for cellulites and cosmetic use
US20090220488A1 (en) * 2005-08-31 2009-09-03 Humphrey Gardner Evaluating and treating scleroderma
WO2007100590A2 (en) * 2006-02-22 2007-09-07 Auxilium Pharmaceuticals, Inc. Methods for treating cellulite
US7569221B2 (en) * 2006-11-10 2009-08-04 Health Research, Inc. Compositions and methods for identifying agents that alter expression of survivin
FR2930154B1 (fr) * 2008-04-21 2012-04-20 Oreal Utilisation d'un extrait de baie, et plus particulierement de wolfberry, pour maintenir et/ou restaurer la tonicite et/ou la fermete de la peau
KR20110074611A (ko) * 2008-10-21 2011-06-30 노보더믹스 인터내셔널 리미티드 상피 조직의 치료 조성물
US9132294B2 (en) * 2010-06-30 2015-09-15 Avon Products, Inc. Compositions and methods for stimulation MAGP-1 to improve the appearance of skin

Also Published As

Publication number Publication date
ES2647895T3 (es) 2017-12-27
CN104603616B (zh) 2017-03-08
US20150301064A1 (en) 2015-10-22
US10718782B2 (en) 2020-07-21
CN104603616A (zh) 2015-05-06
JP6049862B2 (ja) 2016-12-21
EP2893345A1 (en) 2015-07-15
WO2014038097A1 (en) 2014-03-13
EP2893345B1 (en) 2017-11-08
JP2015530071A (ja) 2015-10-15
US9933436B2 (en) 2018-04-03
US20180196064A1 (en) 2018-07-12

Similar Documents

Publication Publication Date Title
HK1209736A1 (zh) -取代的苯甲酰胺及其使用方法
SG11201504022RA (en) Glutamase inhibitors and method of use
EP2811897A4 (en) MEDICAL TERMINAL AND APPLICATION METHOD
EP2912178A4 (en) SUPER AMPLIFIER AND METHOD FOR USE THEREOF
HK1212977A1 (zh) 苯達莫司汀衍生物及其使用方法
PL2892422T3 (pl) Szereg elektrod i sposób mierzenia za ich pomocą
HUE043853T2 (hu) GSK3 inhibitorok és eljárások azok alkalmazására
EP2928384A4 (en) ANCHORS CAPTURED BY THE FABRIC AND METHOD OF USE
EP2864004A4 (en) DEVICE WITH ADAPTABLE DEBATMENT LENGTH, AND METHOD OF USE
EP2874647A4 (en) METHOD FOR DIAGNOSIS AND TREATMENT
EP2863205A4 (en) METHOD AND DEVICE FOR EVALUATING SKIN
HK1207968A1 (zh) 抑制劑及其使用方法
GB2498853B (en) Drug evaluation method and drug evaluation device
HK1222129A1 (zh) 脱氧野尻霉素衍生物及其使用方法
IL226984A0 (en) Device and method for measuring resistance of an object
EP2852397A4 (en) HUWENTOXIN IV VARIANTS AND METHODS OF USE
PL2743712T3 (pl) Urządzenie testujące i sposób testowania
HK1180858A1 (zh) 種跨平台顯示應用的方法及裝置
EP2988675C0 (en) METHOD AND DEVICE FOR THE QUANTITATIVE DYNAMIC EVALUATION OF THE FUNCTIONALITY OF SKELETON MUSCLES
EP2909606A4 (en) DEVICE AND METHOD FOR USING THE DEVICE FOR THE DETECTION OF AMINO ACIDOPATHIES
EP2875343A4 (en) MICROFLUIDIC NANOFLUIDIC DEVICES FOR THE DETECTION AND MEASUREMENT OF REDOX-ACTIVE SUBSTANCES
EP2850895A4 (en) METHOD AND DEVICES FOR PROVIDING AN ADDITIONAL SPECIAL PART FRAME CONFIGURATION
HK1210264A1 (zh) 使用纖蛋白- 和/或肌聚糖γ作為指標評價脂肪團的方法和評價脂肪團有效藥物的方法
GB201213805D0 (en) Alignment device and method of alignment using an alignment device
EP2880432A4 (en) POSITIONABLE SENSOR AND METHOD OF USE